How do you choose the right DPP-4 inhibitor for your patients with type 2 diabetes?
Onglyza vs SU*
*Onglyza 5 mg + metformin was considered non-inferior to glipizide + metformin as the upper limit of the 95% confidence of the treatment difference in the per protocol (PP) analysis was <0.35 at 1 year.
Mean baseline HbA1c of 7.5% for both groups. PP analysis: n=293 in each arm.
1. Goke B et al. Int J Clin Pract 2010; 64(12): 1619-1631.
2. Goke B et al. Int J Clin Pract 2013; 67(4): 307-316.